Dosulepin overdose risk

It is estimated that every year, up to 200 people in England and Wales commit suicide or fatally overdose with dosulepin (BAN name dothiepin).

The Commission on Human Medicines has advised that safety concerns due to the toxicity of dosulepin in overdose are sufficient to discourage its use in new patients.

In addition, only specialist-care prescribers should start treatment for patients who have not previously received dosulepin, and prescribers should limit the amount issued per prescription.

A maximum prescription equivalent to two weeks’ supply of 75mg per day should be considered in patients with increased risk factors for suicide

Further information: MHRA

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Emollients, Potential Skin Sensitisers as Ingredients

Emollients, Potential Skin Sensitisers as Ingredients

Potential sensitising agents in emollient preparations.

Ophthalmic Preparations, Preservatives and Potential Sensitisers as Ingredients

Ophthalmic Preparations, Preservatives and Potential Sensitisers as Ingredients

Potential sensitising agents in eye drops and ointments.

Anti-Anginal Preparations, Summary by Pharmacological Class

Anti-Anginal Preparations, Summary by Pharmacological Class

Available formulations of anti-anginal drugs.

Researchers query safety of delaying antibiotics for UTI in elderly

Researchers query safety of delaying antibiotics for UTI in elderly

Delaying or withholding antibiotics for symptoms of...